Trending Now
SPY turns red typical of last 2 trading friday’s
Futures are down slightly this morning. The SPY is currently sitting at 333 after having just touch on 334 a few minutes...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Hollywall Entertainment Inc (OTCMKTS:HWAL): Under-the-Radar NFT Star in the Making? (PLBY,...
The NFT marketplace has taken the world by storm in 2021. We make the case here that the maturation of the NFT...
MAKE IT MODERN
LATEST REVIEWS
Markets pull back fearing the second COVID-19 wave
Markets are pulling back a little bit after a nice run yesterday. There’s a lot of chop that keeps taking out traders...
MAKE IT MODERN
PERFORMANCE TRAINING
Churchill Capital IV (NYSE:CCIV) could be the next Tesla (NASDAQ:TSLA)
Churchill Capital IV (NYSE:CCIV) hit a new high today, as investors continue to believe it will soon announce a merger with luxury electric-vehicle (EV)...
Anavex Life Sciences Corp (NASDAQ: AVXL) Releases Results of ANAVEX2-73 Study In Prevention of...
Anavex Life Sciences Corp (NASDAQ: AVXL) has released data that showed ANAVEX2-73 to be a preventive medication in Alzheimer’s disease pharmacological model.
ANAVEX2-73 showed protective...
Mustang Bio Inc. (NASDAQ:MBIO) Commences Dosing Of Patients With MB-102 And Enters Agreement With...
Mustang Bio Inc. (NASDAQ:MBIO) has announced the dosing of the first patient in its multicentre, Open-label phase 1/2 study evaluating efficacy and safety of...
Precigen Inc (NASDAQ: PGEN) Announces Definitive Agreement For The Sale Of Tran Ova Genetics...
Precigen Inc (NASDAQ: PGEN) has announced a definitive agreement to sell its wholly-owned animal reproductive technology subsidiary Trans Ova Genetics L.C. to URUS for...
Will Alnylam Pharma (ALNY) could keep surging ?
Alnylam Pharmaceuticals, Inc. (ALNY) experienced a positive movement in its stock price, closing at $240.15, which was up by $17.25 or 7.74%...
MAKE IT MODERN
